1 Influenza |
9 |
8227 |
Risk Ratio (M‐H, Random, 95% CI) |
0.30 [0.19, 0.45] |
1.1 Live attenuated vaccines (1 dose) |
5 |
3556 |
Risk Ratio (M‐H, Random, 95% CI) |
0.33 [0.18, 0.62] |
1.2 Live attenuated vaccines (2 doses) |
2 |
3043 |
Risk Ratio (M‐H, Random, 95% CI) |
0.11 [0.04, 0.26] |
1.3 Inactivated vaccines (1 dose) |
5 |
1628 |
Risk Ratio (M‐H, Random, 95% CI) |
0.36 [0.28, 0.48] |
1.4 Inactivated vaccines (2 doses) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
2 Influenza‐like illness |
8 |
143650 |
Risk Ratio (M‐H, Random, 95% CI) |
0.69 [0.62, 0.77] |
2.1 Live attenuated vaccines (1 dose) |
2 |
3306 |
Risk Ratio (M‐H, Random, 95% CI) |
0.64 [0.18, 2.22] |
2.2 Live attenuated vaccines (2 doses) |
6 |
121300 |
Risk Ratio (M‐H, Random, 95% CI) |
0.66 [0.57, 0.76] |
2.3 Inactivated vaccines (1 dose) |
2 |
267 |
Risk Ratio (M‐H, Random, 95% CI) |
0.35 [0.15, 0.81] |
2.4 Inactivated vaccines (2 doses) |
2 |
18777 |
Risk Ratio (M‐H, Random, 95% CI) |
0.72 [0.69, 0.76] |
3 Secondary cases |
1 |
123 |
Risk Ratio (M‐H, Random, 95% CI) |
1.68 [0.56, 4.99] |
3.1 Live attenuated vaccines (1 dose) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
3.2 Live attenuated vaccines (2 doses) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
3.3 Inactivated vaccines (1 dose) |
1 |
123 |
Risk Ratio (M‐H, Random, 95% CI) |
1.68 [0.56, 4.99] |
3.4 Inactivated vaccines (2 doses) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
4 School absenteeism |
1 |
550 |
Risk Ratio (M‐H, Random, 95% CI) |
0.49 [0.26, 0.92] |
4.1 Live attenuated vaccines (1 dose) |
1 |
296 |
Risk Ratio (M‐H, Random, 95% CI) |
0.51 [0.22, 1.19] |
4.2 Live attenuated vaccines (2 doses) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
4.3 Inactivated vaccines (1 dose) |
1 |
254 |
Risk Ratio (M‐H, Random, 95% CI) |
0.46 [0.17, 1.22] |
4.4 Inactivated vaccines (2 doses) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
5 Lower respiratory tract disease |
2 |
1632 |
Risk Ratio (M‐H, Random, 95% CI) |
0.20 [0.03, 1.54] |
5.1 Live attenuated vaccines (1 dose) |
2 |
1496 |
Risk Ratio (M‐H, Random, 95% CI) |
0.16 [0.01, 4.45] |
5.2 Live attenuated vaccines (2 doses) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
5.3 Inactivated vaccines (1 dose) |
1 |
136 |
Risk Ratio (M‐H, Random, 95% CI) |
0.30 [0.01, 6.17] |
5.4 Inactivated vaccines (2 doses) |
0 |
0 |
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
6 Acute otitis media |
6 |
5253 |
Risk Ratio (M‐H, Random, 95% CI) |
1.00 [0.79, 1.26] |
6.1 Live attenuated vaccines (1 dose) |
3 |
2585 |
Risk Ratio (M‐H, Random, 95% CI) |
0.42 [0.05, 3.79] |
6.2 Live attenuated vaccines (2 doses) |
1 |
1784 |
Risk Ratio (M‐H, Random, 95% CI) |
0.98 [0.95, 1.01] |
6.3 Inactivated vaccines (1 dose) |
1 |
136 |
Risk Ratio (M‐H, Random, 95% CI) |
1.52 [0.10, 23.76] |
6.4 Inactivated vaccines (2 doses) |
2 |
748 |
Risk Ratio (M‐H, Random, 95% CI) |
1.15 [0.95, 1.40] |
7 Hospitalisation due to acute otitis media |
2 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Subtotals only |
7.1 Inactivated vaccine (2 doses) |
2 |
765 |
Risk Ratio (M‐H, Random, 95% CI) |
1.41 [0.62, 3.24] |
8 Consequences of acute otitis media |
2 |
|
Mean Difference (IV, Random, 95% CI) |
Subtotals only |
8.1 Inactivated vaccine (2 (doses of the intervention) ‐ visits (outcome measure)) |
2 |
765 |
Mean Difference (IV, Random, 95% CI) |
‐0.02 [‐0.27, 0.23] |
8.2 Inactivated vaccine (2 doses; courses of antibiotics) |
2 |
765 |
Mean Difference (IV, Random, 95% CI) |
0.13 [‐0.36, 0.63] |
9 Outpatients attendance for pneumonia and influenza |
2 |
2874 |
Risk Ratio (M‐H, Random, 95% CI) |
0.76 [0.59, 0.98] |
9.1 Live attenuated vaccine (1 dose) |
1 |
1090 |
Risk Ratio (M‐H, Random, 95% CI) |
0.65 [0.49, 0.85] |
9.2 Live attenuated vaccine (2 doses) |
1 |
1784 |
Risk Ratio (M‐H, Random, 95% CI) |
0.85 [0.75, 0.96] |
10 Working days lost (number of events, parents of children 6 to 36 months of age) |
2 |
2874 |
Risk Ratio (M‐H, Random, 95% CI) |
0.69 [0.46, 1.03] |
10.1 Live attenuated vaccine |
2 |
2874 |
Risk Ratio (M‐H, Random, 95% CI) |
0.69 [0.46, 1.03] |
11 Drug prescriptions (number of events, 6 to 36 months of age) |
1 |
1784 |
Risk Ratio (M‐H, Random, 95% CI) |
0.99 [0.87, 1.12] |
11.1 Live attenuated vaccine |
1 |
1784 |
Risk Ratio (M‐H, Random, 95% CI) |
0.99 [0.87, 1.12] |